Aptamer-target interaction descriptor
Aptamer-target interaction information
Interaction ID: 198
Aptamer sequence: AGGAAGGCTTTAGGGTCTGAGATCTCGGGAAT
Target unique ID: P04585
Aptamer ID Aptamer descriptor Target chemistry Target name Affinity Binding Conditions/Buffer PubMed ID
Apta_194 PF1-3G2 Protein POL_HV1H2 260 nM 50 mM Tris-HCl, pH 8, 1mM DTT, 80 mM KCl, 6 mM MgCl2 for ten minutes 22554064
Structure information of aptamer
Aptamer Sequence: AGGAAGGCTTTAGGGTCTGAGATCTCGGGAAT
The optimal secondary structure in dot-bracket notation: ....(((((....)))))..............
The centroid secondary structure in dot-bracket notation: .....(((......)))...............
The MFE structure
The Centroid structure
The mountain plot representation
Aptamer information
Type Detail Type Detail
Aptamer ID Apta_194 Description PF1-3G2
Aptamer chemistry DNA Length 32 nt
GC content 50.0% Molecular weight 10,224.37 Da
Molarity of 1 μg/μl solution 97.81 μM Number of G-quadruplexes No QGRS found
G-Score N/A Function Targeted therapy
Sequence AGGAAGGCTTTAGGGTCTGAGATCTCGGGAAT
Applications Inhibiting function against the WT HIV-1 RT
Target information
Type Detail Type Detail
Uniprot ID P04585 Protein name Gag-Pol polyprotein (Pr160Gag-Pol) [Cleaved into: Matrix protein p17 (MA); Capsid protein p24 (CA); Spacer peptide 1 (SP1) (p2); Nucleocapsid protein p7 (NC); Transframe peptide (TF); p6-pol (p6*); Protease (EC 3.4.23.16) (PR) (Retropepsin); Reverse transcriptase/ribonuclease H (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.13) (Exoribonuclease H) (EC 3.1.13.2) (p66 RT); p51 RT; p15; Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-)]
Gene name(s) gag-pol Organism Gag-Pol polyprotein (Pr160Gag-Pol) [Cleaved into: Matrix protein p17 (MA); Capsid protein p24 (CA); Spacer peptide 1 (SP1) (p2); Nucleocapsid protein p7 (NC); Transframe peptide (TF); p6-pol (p6*); Protease (EC 3.4.23.16) (PR) (Retropepsin); Reverse transcriptase/ribonuclease H (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.13) (Exoribonuclease H) (EC 3.1.13.2) (p66 RT); p51 RT; p15; Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-)]
Status reviewed in uniprot database Length 1435
Mass 162,042 Activity regulation The viral protease is inhibited by many synthetic protease inhibitors (PIs), such as amprenavir, atazanavir, indinavir, loprinavir, nelfinavir, ritonavir and saquinavir
Involvement in disease N/A Catalytic activity Reaction=Specific for a P1 residue that is hydrophobic, and P1' variable
PDB ID(s)
1A30;1BV7;1BV9;1BVE;1BVG;1BWA;1BWB;1C0T;1C0U;1C1B;1C1C;1DMP;1DTQ;1DTT;1E6J;1EP4;1ESK;1EX4;1EXQ;1FB7;1FK9;1FKO;1FKP;1G6L;1HIV;1HVH;1HVR;1HWR;1HXB;1JKH;1JLA;1JLB;1JLC;1JLE;1JLF;1JLG;1JLQ;1KLM;1LV1;1LW0;1LW2;1LWC;1LWE;1LWF;1NCP;1O1W;1ODW;1ODY;1QBR;1QBS;1QBT;1QBU;1REV;1RT1;1RT2;1RT3;1RT4;1RT5;1RT6;1RT7;1RTD;1RTH;1RTI;1RTJ;1S1T;1S1U;1S1V;1S1W;1S1X;1T05;1TAM;1TKT;1TKX;1TKZ;1TL1;1TL3;1VRT;1VRU;2HND;2HNY;2HNZ;2KOD;2NPH;2OPP;2OPQ;2OPR;2OPS;2RF2;2RKI;2WHH;2WOM;2WON;2YNF;2YNG;2YNH;2YNI;3AO2;3C6T;3C6U;3DI6;3DLE;3DLG;3DM2;3DMJ;3DOK;3DOL;3DOX;3DRP;3DRR;3DRS;3DYA;3E01;3FFI;3I0R;3I0S;3KJV;3KK1;3KK2;3KK3;3KT2;3KT5;3LAK;3LAL;3LAM;3LAN;3LP0;3LP1;3LP2;3M8P;3M8Q;3MEC;3MED;3MEE;3MEG;3N3I;3NBP;3PHV;3QIN;3QIO;3QIP;3T19;3T1A;3TAM;4B3O;4B3P;4B3Q;4I7F;4KSE;4KV8;4NCG;4Q1W;4Q1X;4Q1Y;4Q5M;4QLH;4U1H;4U1I;4U1J;4U7Q;4U7V;5DGU;5DGW;5EU7;5HRN;5HRP;5HRR;5HRS;5IM7;5J2M;5J2N;5J2P;5J2Q;5K14;5KAO;5T82;5TC2;5VZ6;5XOS;5XOT;5YRS;6BJ2;6BJ3;6BSG;6BSH;6BSI;6BSJ;6DIF;6DIL;6DJ1;6DJ2;6DJ5;6DJ7;6DV0;6DV4;6E7J;6E9A;6EWA;6EX9;6GL1;6J1V;6J1W;6OR7;6OTZ;6P1I;6P1X;6P2G;6PYL;6SKK;6SKM;6SKN;6SLQ;6SLU;6SMU;6UIR;6UIS;6UIT;6UJX;6UJY;6UJZ;6UK0;6VPZ;6VQ2;6VQD;6VQE;6VQY;6VQZ;6WAZ;6WB1;6WPF;6WPH;6WPJ;
Function Mediates, with Gag polyprotein, the essential events in virion assembly, including binding the plasma membrane.
Activity data

No relevant experimental diagram

Interaction ID 198
Target type Protein
Target unique ID P04585
Activity 260 nM
Binding Conditions/Buffer

50 mM Tris-HCl, pH 8, 1mM DTT, 80 mM KCl, 6 mM MgCl2 for ten minutes

Assay

N/A

PubMed ID 22554064
Similar aptamers
Aptamer ID Aptamer chemistry Sequence Similarity
Apta_193 DNA AGGAAGGCTTTAGGGTCTGAGATCTCGGAAT
96.88%
Apta_184 DNA AGGAAGGCTTTAGGTCTGAGATCTCGGAAT
93.75%
Apta_195 DNA AGGAAGGCTTTAGGGGTCTGAGATCTCGGAAT
93.75%
Apta_186 DNA AGGAACGCTTTAGGTCTGAGATCTCGGAAT
90.62%
Apta_192 DNA AGGAAGGCTTTAGCTCTGAGATCTCGGAAT
90.62%
Apta_215 DNA AGGAAGGCTTTAGGTCCGAGATCTCGGAAT
90.62%
Apta_190 DNA AGGAACCCTTTAGGTCTGAGATCTCGGAAT
87.50%
Apta_191 DNA AGGAAGGCTTTACCTCTGAGATCTCGGAAT
87.50%
Apta_202 DNA AAGGCTTTAGGTCTGAGATCTCGGAAT
84.38%
Apta_185 DNA ACCAAGGCTTTAGGTCTGAGATCTCCCAAT
81.25%
Apta_189 DNA AGGAACCCTTTACCTCTGAGATCTCGGAAT
81.25%
Apta_203 DNA GGAAGGCTTTAGGTCTGAGATCTCGG
81.25%
Apta_196 DNA AGGAAGGCTTTAGGTCTGAGATCTC 78.12%
Apta_197 DNA GGCTTTAGGTCTGAGATCTCGGAAT 78.12%
Apta_206 DNA AGGAAGGGGTCTGAGATCTCGGAAT 78.12%
Apta_205 DNA TTAAGGCTTTAGGTCTGAGATCTCTT 71.88%
Apta_187 DNA ACCAACCCTTTACCTCTGAGATCTCCCAAT 68.75%
Apta_188 DNA AAAAAAACTTTAAATCTGAGATCTCAAAAT 68.75%
Apta_204 DNA CCAAGGCTTTAGGTCTGAGATCTCCC 68.75%
Apta_212 RNA AGGAAGGCUUUAGGUCUGAGAUCUCGGAAU 68.75%